Manufacturers/Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

92 drugs in NADAC|0 Generic,92 Brand

View Recalls (7)

Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file (0 generic, 92 brand), at an average NADAC of $766.98 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

92

0G / 92B

Avg Price / Unit

$766.9839

$0.44 – $24369.37

Avg 7d Change

0.00%

Across 29 drugs with changes

7d Activity

13↑16↓63 flat

of 92 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does Novartis Pharmaceuticals Corporation make?

Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file — 0 generic and 92 brand products.

What is the average price of Novartis Pharmaceuticals Corporation drugs?

The average NADAC across Novartis Pharmaceuticals Corporation's portfolio is $766.9839 per unit, ranging from $0.4367 to $24369.3694.

What types of drugs does Novartis Pharmaceuticals Corporation make?

Novartis Pharmaceuticals Corporation makes drugs across 24 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (25), Central Nervous System Stimulant (17), Calcium Channel Blocker (13), Dihydropyridine Calcium Channel Blocker (13), Kinase Inhibitor (10).

Has Novartis Pharmaceuticals Corporation had any drug recalls?

7 FDA recalls are matched to Novartis Pharmaceuticals Corporation in the openFDA feed, most recently on Aug 4, 2026.

How has Novartis Pharmaceuticals Corporation's pricing changed recently?

Over the past 7 days, 13 Novartis Pharmaceuticals Corporation products rose and 16 fell, with a portfolio-wide average change of +0.0%.

Drug Portfolio

92 drugs total, 92 shown

Drug ↕Price 7d Change ↕
KESIMPTA 20 MG/0.4 ML PEN
ofatumumab
$24369.3694
per ML
-0.04%
COSENTYX 150 MG/ML SYRINGE
secukinumab
$7879.8111
per ML
+0.13%
COSENTYX SENSOREADY 150 MG/ML PEN
secukinumab
$7858.4754
per ML
+0.05%
SANDOSTATIN LAR DEPOT 30 MG KT
octreotide acetate
$6948.0840
per EA
—
SANDOSTATIN LAR DEPOT 20 MG KT
octreotide acetate
$4588.5469
per EA
—
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)
secukinumab
$4087.4067
per ML
-0.02%
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)
secukinumab
$3946.3486
per ML
+0.12%
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES
secukinumab
$3924.3531
per ML
—
SANDOSTATIN LAR DEPOT 10 MG KT
octreotide acetate
$3523.0291
per EA
—
AFINITOR 10 MG TABLET
everolimus
$462.0394
per EA
—
GILENYA 0.5 MG CAPSULE
Fingolimod hcl
$414.7110
per EA
—
KISQALI 400 MG DAILY DOSE
ribociclib
$346.9469
per EA
—
GLEEVEC 400 MG TABLET
imatinib mesylate
$328.0342
per EA
—
GLEEVEC 400 MG TABLET
imatinib mesylate
$328.0342
per EA
—
KISQALI 600 MG DAILY DOSE
ribociclib
$289.7167
per EA
—
TASIGNA 200 MG CAPSULE
nilotinib
$94.1452
per EA
—
TASIGNA 200 MG CAPSULE
nilotinib
$94.1452
per EA
—
GLEEVEC 100 MG TABLET
imatinib mesylate
$90.8197
per EA
—
TOBRADEX EYE OINTMENT
tobramycin and dexamethasone
$89.7148
per GM
-0.01%
TOBREX 0.3% EYE OINTMENT
tobramycin
$84.4145
per GM
-0.12%
BETOPTIC S 0.25% EYE DROP
betaxolol hydrochloride
$42.8790
per ML
—
BETOPTIC S 0.25% EYE DROP
betaxolol hydrochloride
$42.6242
per ML
—
AZOPT 1% EYE DROPS
brinzolamide
$35.1697
per ML
—
FEMARA 2.5 MG TABLET
letrozole
$27.1160
per EA
—
ZORTRESS 0.75 MG TABLET
everolimus
$27.0419
per EA
—
EXELON 13.3 MG/24HR PATCH
rivastigmine
$22.0078
per EA
—
EXELON 4.6 MG/24HR PATCH
rivastigmine
$21.8721
per EA
-0.06%
EXELON 9.5 MG/24HR PATCH
rivastigmine
$21.8083
per EA
—
TRILEPTAL 600 MG TABLET
oxcarbazepine
$19.3327
per EA
+0.12%
ZORTRESS 0.5 MG TABLET
everolimus
$17.8041
per EA
—
DIOVAN HCT 320-25 MG TABLET
valsartan and hydrochlorothiazide
$16.3796
per EA
—
LOTREL 10-40 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$15.6209
per EA
—
EXFORGE HCT 10-320-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$15.4477
per EA
—
EXFORGE 10-320 MG TABLET
amlodipine besylate and valsartan
$15.3942
per EA
—
SANDIMMUNE 100 MG CAPSULE
cyclosporine
$15.3370
per EA
—
MYFORTIC 360 MG TABLET
mycophenolic acid
$14.9342
per EA
—
DIOVAN HCT 160-25 MG TABLET
valsartan and hydrochlorothiazide
$13.0470
per EA
—
RITALIN LA 40 MG CAPSULE
methylphenidate hydrochloride
$12.7255
per EA
—
DIOVAN 320 MG TABLET
valsartan
$12.6745
per EA
-0.04%
RITALIN LA 30 MG CAPSULE
methylphenidate hydrochloride
$12.3878
per EA
—
LOTREL 5-20 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$12.2080
per EA
—
EXFORGE 10-160 MG TABLET
amlodipine besylate and valsartan
$12.1271
per EA
—
RITALIN LA 20 MG CAPSULE
methylphenidate hydrochloride
$12.1023
per EA
—
RITALIN LA 10 MG CAPSULE
methylphenidate hydrochloride
$12.0700
per EA
—
XIIDRA 5% EYE DROPS
Lifitegrast
$11.8320
per EA
+0.01%
DIOVAN HCT 320-12.5 MG TAB
valsartan and hydrochlorothiazide
$11.7935
per EA
—
NEORAL 100 MG GELATIN CAPSULE
cyclosporine
$11.7731
per EA
—
ENTRESTO SPRINKLE 15-16 MG PLT
Sacubitril and Valsartan
$11.6067
per EA
-0.18%
ENTRESTO 24 MG-26 MG TABLET
Sacubitril and Valsartan
$11.5927
per EA
-0.03%
ENTRESTO 24 MG-26 MG TABLET
Sacubitril and Valsartan
$11.5927
per EA
-0.03%
ENTRESTO 97 MG-103 MG TABLET
Sacubitril and Valsartan
$11.5887
per EA
-0.02%
ENTRESTO 97 MG-103 MG TABLET
Sacubitril and Valsartan
$11.5887
per EA
-0.02%
ENTRESTO 49 MG-51 MG TABLET
Sacubitril and Valsartan
$11.5606
per EA
+0.03%
ENTRESTO 49 MG-51 MG TABLET
Sacubitril and Valsartan
$11.5606
per EA
+0.03%
LOTREL 5-10 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$11.5553
per EA
—
DIOVAN HCT 160-12.5 MG TAB
valsartan and hydrochlorothiazide
$11.4764
per EA
+0.10%
LOTREL 10-20 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$11.2952
per EA
—
EXFORGE 5-320 MG TABLET
amlodipine besylate and valsartan
$10.9314
per EA
—
EXFORGE 5-160 MG TABLET
amlodipine besylate and valsartan
$10.6508
per EA
—
DIOVAN HCT 80-12.5 MG TABLET
valsartan and hydrochlorothiazide
$10.5648
per EA
—
TRILEPTAL 300 MG TABLET
oxcarbazepine
$10.4543
per EA
-0.02%
DIOVAN 160 MG TABLET
valsartan
$10.0377
per EA
+0.07%
EXFORGE HCT 10-160-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$9.7743
per EA
—
DIOVAN 80 MG TABLET
valsartan
$9.3271
per EA
-0.07%
EXFORGE HCT 5-160-12.5 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.5559
per EA
—
EXFORGE HCT 10-160-12.5 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.4532
per EA
—
EXFORGE HCT 5-160-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.4511
per EA
—
DIOVAN 40 MG TABLET
valsartan
$7.8163
per EA
—
MYFORTIC 180 MG TABLET
mycophenolic acid
$7.4331
per EA
—
TEGRETOL XR 400 MG TABLET
carbamazepine
$6.4900
per EA
+0.09%
TRILEPTAL 150 MG TABLET
oxcarbazepine
$5.7216
per EA
—
FOCALIN XR 35 MG CAPSULE
dexmethylphenidate hydrochloride
$5.4251
per EA
—
FOCALIN XR 40 MG CAPSULE
dexmethylphenidate hydrochloride
$5.4141
per EA
—
COARTEM TABLETS
artemether and lumefantrine
$5.3628
per EA
—
FOCALIN XR 25 MG CAPSULE
dexmethylphenidate hydrochloride
$5.1291
per EA
—
FOCALIN XR 15 MG CAPSULE
dexmethylphenidate hydrochloride
$4.9146
per EA
—
FOCALIN XR 20 MG CAPSULE
dexmethylphenidate hydrochloride
$4.9070
per EA
—
FOCALIN XR 10 MG CAPSULE
dexmethylphenidate hydrochloride
$4.7606
per EA
—
FOCALIN XR 30 MG CAPSULE
dexmethylphenidate hydrochloride
$4.7451
per EA
-0.18%
FOCALIN XR 5 MG CAPSULE
dexmethylphenidate hydrochloride
$4.7035
per EA
—
SANDIMMUNE 25 MG CAPSULE
cyclosporine
$4.3773
per EA
—
TEGRETOL XR 200 MG TABLET
carbamazepine
$3.2473
per EA
+0.12%
TEGRETOL 200 MG TABLET
carbamazepine
$3.0397
per EA
-0.10%
NEORAL 25 MG GELATIN CAPSULE
cyclosporine
$2.9457
per EA
—
TRILEPTAL 300 MG/5 ML SUSP
oxcarbazepine
$1.9308
per ML
+0.03%
RITALIN 20 MG TABLET
methylphenidate hydrochloride
$1.6330
per EA
—
TEGRETOL XR 100 MG TABLET
carbamazepine
$1.6281
per EA
+0.05%
FOCALIN 10 MG TABLET
dexmethylphenidate hydrochloride
$1.3297
per EA
—
RITALIN 10 MG TABLET
methylphenidate hydrochloride
$1.1332
per EA
—
FOCALIN 5 MG TABLET
dexmethylphenidate hydrochloride
$0.9206
per EA
—
RITALIN 5 MG TABLET
methylphenidate hydrochloride
$0.7953
per EA
—
TEGRETOL 100 MG/5 ML SUSP
carbamazepine
$0.4367
per ML
-0.06%

FDA Recalls (7)

Recalls matched by company name. Verify current status with FDA.

D-0746-2026 →
Ongoing
Class II

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

Failed Dissolution Specifications

Initiated: 8/4/2026
D-0144-2024 →
Ongoing
Class I

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Initiated: 11/22/2023
D-1543-2022 →
Terminated
Class II

Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.

CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

Initiated: 9/16/2022
D-0982-2022 →
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) and b) 5- Single-Use Containers (NDC 0078-0911-05) Rx Only, Manufactured by: The Ritedose Corporation, Columbia, SC 29203, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0983-2022 →
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 54092-606-01) and b) 5-Single-Use Containers (NDC 54092-606-06), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0984-2022 →
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-95) and b) 4 pouches x 5 single-use containers (NDC 0078-0911-94), Rx Only, Manufactured by: The Ritedose Corporation Columbia, SC 29203; Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0985-2022 →
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022